Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lake Street Downgrades Apollo Endosurgery to Hold, Lowers Price Target to $10

Author: Benzinga Newsdesk | November 30, 2022 10:16am

Lake Street analyst Frank Takkinen downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and lowers the price target from $14 to $10.

Posted In: APEN